Join to View Full Profile
9500 Euclid AveCleveland, OH 44195
Phone+1 216-444-2200
Fax+1 216-445-3889
Dr. Qazi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Taha Qazi is a gastroenterologist in Boston, MA and is affiliated with multiple hospitals in the area, including Boston Medical Center, Cleveland Clinic, and Lawrence General Hospital. He received his medical degree from Indiana University School of Medicine and has been in practice 6 years. He specializes in inflammatory bowel disease.
Education & Training
Boston University Medical CenterFellowship, Advanced Inflammatory Bowel Disease, 2018 - 2019
Mass General Brigham/Brigham and Women's HospitalFellowship, Gastroenterology, 2015 - 2018- Boston University Medical CenterResidency, Gastroenterology, 2011 - 2018
- Boston University Medical CenterChief Residency, Internal Medicine, 2014 - 2015
Indiana University School of MedicineClass of 2011
Certifications & Licensure
OH State Medical License 2019 - 2026
IN State Medical License 2024 - 2025
MA State Medical License 2014 - 2025
WV State Medical License 2024 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel Disease Start of enrollment: 2021 Mar 22
Publications & Presentations
PubMed
- Colorectal Cancer and Inflammatory Bowel Disease.Maysoon Gamaleldin, Taha Qazi, Tracy Hull
Clinics in Colon and Rectal Surgery. 2025-05-01 - Cellular and molecular mechanisms in the pathogenesis of pouchitis: more than just the microbiota.Manuel B Braga-Neto, Taha Qazi, Clifton Fulmer, Stefan D Holubar, Claudio Fiocchi
Gut. 2025-04-16 - The Clinical Utility of Precision-Guided Dosing for Adalimumab Therapy Optimization in Inflammatory Bowel Disease: A Clinical Experience Program.Stephen B Hanauer, Esther A Torres, Patricia Aragon-Han, Jonathon C Chapman, Arun C Swaminath
Pharmaceutics. 2025-03-27
Press Mentions
5 Great Nutrition Apps That Can Help You Manage IBDSeptember 2nd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
